Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy

BACKGROUND: Epidermal growth factor (EGF) is implicated in the pathogenesis of schizophrenia, suggesting possible value as a biomarker for disease severity or treatment response. However, basal EGF levels and changes during treatment are inconsistent across studies. The goal of this study is to comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaobin, Xiao, Wenhuan, Chen, KuanYu, Zhao, Yaqin, Ye, Fei, Tang, Xiaowei, Du, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062789/
https://www.ncbi.nlm.nih.gov/pubmed/32194452
http://dx.doi.org/10.3389/fpsyt.2020.00104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062789/
https://www.ncbi.nlm.nih.gov/pubmed/32194452
http://dx.doi.org/10.3389/fpsyt.2020.00104

Ejemplares similares